Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;7(7):474-6.

New cytokine targets in inflammatory bowel disease

Thomas T Macdonald  1
Affiliations

New cytokine targets in inflammatory bowel disease

Thomas T Macdonald. Gastroenterol Hepatol (N Y). 2011 Jul.
No abstract available

PubMed Disclaimer

References

    1. Colombel JF, Sandborn WJ, Reinisch W, et al. SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362:1383–1395. - PubMed
    1. Fantini MC, Monteleone G, MacDonald TT. IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol. 2008;1:110–115. - PubMed
    1. MacDonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology. 2011;140:1768–1775. - PubMed
    1. MacDonald TT. Inside the microbial and immune labyrinth: totally gutted. Nat Med. 2010;16:1194–1195. - PubMed
    1. Sandborn WJ, Feagan BG, Fedorak RN, et al. Ustekinumab Crohn's Disease Study Group. A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology. 2008;135:1130–1141. - PubMed

LinkOut - more resources